Stockreport

European Medicines Agency (EMA) Grants Orphan Drug Designation for Moleculin's Treatment of Acute Myeloid Leukemia (AML) [Yahoo! Finance]

Moleculin Biotech, Inc.  (MBRX) 
Last moleculin biotech, inc. earnings: 8/16 05:35 pm Check Earnings Report
US:NASDAQ Investor Relations: moleculin.com/investors
PDF – There are approximately 160,000 people with AML worldwide – Annamycin continues to show no signs of cardiotoxicity (N=82 across multiple studies); Lower toxicity pr [Read more]